Innovative Functional Product for Overweight and Obesity
Launched by CARMEN LUCAS ABELLÁN · Jun 27, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special product that contains natural plant compounds called polyphenols, which may help people who are overweight or obese. The main goal is to see if this product can improve body weight, how the body uses insulin (which helps control blood sugar), reduce inflammation, and support overall metabolic health. The study compares this product to a placebo (a harmless, inactive substance) to understand its true effects.
Adults aged 18 and older with a body mass index (BMI) between 25 and 35—meaning they are classified as overweight or mildly obese—may be eligible to join. People who have serious illnesses, are pregnant or breastfeeding, take antioxidant supplements, or have allergies to the product won’t be able to participate. If you join, you’ll be randomly assigned to receive either the polyphenol product or a placebo without knowing which one you get, and the researchers, doctors, and staff won’t know either, to keep the study fair. This helps provide reliable information about whether the product really works to support healthier weight and metabolism.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals of both sexes, aged 18 years or older.
- • Body Mass Index (BMI) between 25 and 35.
- • Clinical diagnosis of overweight or obesity according to established criteria.
- • Ability to understand and sign the informed consent form.
- Exclusion Criteria:
- • Presence of severe or terminal chronic diseases.
- • Current treatment with antioxidants or similar dietary supplements.
- • Known allergies to any of the product components.
- • Pregnancy or breastfeeding.
- • Participation in another clinical trial within the past 3 months.
About Carmen Lucas Abellán
Carmen Lucas Abellán is a clinical trial sponsor dedicated to advancing medical research through the design and oversight of rigorous clinical studies. With a strong commitment to ethical standards and scientific integrity, she focuses on facilitating innovative treatments and improving patient outcomes across various therapeutic areas. Her expertise encompasses trial management, regulatory compliance, and collaboration with multidisciplinary teams to ensure high-quality data and meaningful clinical insights.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Murcia, , Spain
Patients applied
Trial Officials
Carmen Lucas Abellán
Principal Investigator
Universidad Católica San Antonio de Murcia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported